"The US Food and Drug Administration (FDA) has approved naldemedine (Symproic) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic noncancer pain, Shionogi Inc and Purdue Pharma LP have announced."...
Lortab 2.5 (hydrocodone bitartrate and acetaminophen tablets) /500 tablets (Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 2.5 mg/500 mg) are indicated for the relief of moderate to moderately severe pain.
DOSAGE AND ADMINISTRATION
Dosage should be adjusted according to the severity of the pain and the response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.
The usual adult dosage is one or two tablets every four to six hours as needed for pain. The total daily dosage should not exceed 8 tablets.
Lortab ® 2.5/500 tablets (Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 2.5 mg/500mg) contain hydrocodone bitartrate 2.5 mg and acetaminophen 500 mg. They are supplied as white with pink specks, capsule-shaped, bisected tablets, debossed "ucb" on one side and "901" on the other side, in containers of 100 tablets NDC 50474-925-01, and 500 tablets NDC 50474-925-50.
STORAGE: Store at controlled room temperature, 15°-30°C (59°-86°F).
Dispense in a tight, light-resistant container with a child-resistant closure.
A Schedule CIII Narcotic
Manufactured for: UCB Pharma, Inc., Smyrna, GA 30080. Manufactured by: Mikart Inc. Atlanta, GA 30318. FDA rev date: 8/3/2000.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/8/2016
Additional Lortab 2.5 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.